Acknowledgement
This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (2019R1F1A1062761).
References
- Kim SH, Stoicea N, Soghomonyan S, Bergese SD. Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review. Front Pharmacol 2014; 5: 108. https://doi.org/10.3389/fphar.2014.00108
- Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14: 145-61.
- Mao J. Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 2002; 100: 213-7. https://doi.org/10.1016/S0304-3959(02)00422-0
- Mao J, Sung B, Ji RR, Lim G. Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J Neurosci 2002; 22: 8312-23. https://doi.org/10.1523/jneurosci.22-18-08312.2002
- Scholz J, Broom DC, Youn DH, Mills CD, Kohno T, Suter MR, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005; 25: 7317-23. https://doi.org/10.1523/JNEUROSCI.1526-05.2005
- Vanderah TW, Ossipov MH, Lai J, Malan TP Jr, Porreca F. Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin. Pain 2001; 92: 5-9. https://doi.org/10.1016/S0304-3959(01)00311-6
- Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan TP Jr, et al. Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002; 22: 6747-55. https://doi.org/10.1523/jneurosci.22-15-06747.2002
- Yamamoto Y, Ueta Y, Date Y, Nakazato M, Hara Y, Serino R, et al. Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res Mol Brain Res 1999; 65: 14-22. https://doi.org/10.1016/S0169-328X(98)00320-9
- Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999; 98: 365-76. https://doi.org/10.1016/S0092-8674(00)81965-0
- Date Y, Ueta Y, Yamashita H, Yamaguchi H, Matsukura S, Kangawa K, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci U S A 1999; 96: 748-53. https://doi.org/10.1073/pnas.96.2.748
- Jeon Y, Park KB, Pervin R, Kim TW, Youn DH. Orexin-A modulates excitatory synaptic transmission and neuronal excitability in the spinal cord substantia gelatinosa. Neurosci Lett 2015; 604: 128-33. https://doi.org/10.1016/j.neulet.2015.08.001
- Chen J, Sandkuhler J. Induction of homosynaptic long-term depression at spinal synapses of sensory a delta-fibers requires activation of metabotropic glutamate receptors. Neuroscience 2000; 98: 141-8. https://doi.org/10.1016/S0306-4522(00)00080-4
- Park KB, Weon H. Orexin receptors mediate long-term depression of excitatory synaptic transmission in the spinal cord dorsal horn. Neurosci Lett 2017; 660: 12-6. https://doi.org/10.1016/j.neulet.2017.08.068
- Niknia S, Kaeidi A, Hajizadeh MR, Mirzaei MR, Khoshdel A, Hajializadeh Z, et al. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy. Neuropeptides 2019; 73: 34-40. https://doi.org/10.1016/j.npep.2018.11.001
- Yamamoto T, Saito O, Shono K, Aoe T, Chiba T. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett 2003; 347: 183-6. https://doi.org/10.1016/S0304-3940(03)00716-X
- Risold PY, Griffond B, Kilduff TS, Sutcliffe JG, Fellmann D. Preprohypocretin (orexin) and prolactin-like immunoreactivity are coexpressed by neurons of the rat lateral hypothalamic area. Neurosci Lett 1999; 259: 153-6. https://doi.org/10.1016/S0304-3940(98)00906-9
- Araldi D, Ferrari LF, Levine JD. Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain. J Neurosci 2015; 35: 12502-17. https://doi.org/10.1523/JNEUROSCI.1673-15.2015
- Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6. https://doi.org/10.1016/0031-9384(76)90029-9
- Deuis JR, Dvorakova LS, Vetter I. Methods used to evaluate pain behaviors in rodents. Front Mol Neurosci 2017; 10: 284. https://doi.org/10.3389/fnmol.2017.00284
- Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother 2013; 4: 303-6. https://doi.org/10.4103/0976-500X.119726
- Wang Z, Gardell LR, Ossipov MH, Vanderah TW, Brennan MB, Hochgeschwender U, et al. Pronociceptive actions of dynorphin maintain chronic neuropathic pain. J Neurosci 2001; 21: 1779-86. https://doi.org/10.1523/jneurosci.21-05-01779.2001
- Vanderah TW, Laughlin T, Lashbrook JM, Nichols ML, Wilcox GL, Ossipov MH, et al. Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone. Pain 1996; 68: 275-81. https://doi.org/10.1016/S0304-3959(96)03225-3
- Mobarakeh JI, Takahashi K, Sakurada S, Nishino S, Watanabe H, Kato M, et al. Enhanced antinociception by intracerebroventricularly and intrathecally-administered orexin A and B (hypocretin-1 and -2) in mice. Peptides 2005; 26: 767-77. https://doi.org/10.1016/j.peptides.2005.01.001
- Cheng JK, Chou RC, Hwang LL, Chiou LC. Antiallodynic effects of intrathecal orexins in a rat model of postoperative pain. J Pharmacol Exp Ther 2003; 307: 1065-71. https://doi.org/10.1124/jpet.103.056663
- Araldi D, Ferrari LF, Levine JD. Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms. Pain 2017; 158: 1204-16. https://doi.org/10.1097/j.pain.0000000000000898
- de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-7. https://doi.org/10.1073/pnas.95.1.322
- Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-85. https://doi.org/10.1016/S0092-8674(00)80949-6
- Cutler DJ, Morris R, Sheridhar V, Wattam TA, Holmes S, Patel S, et al. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides 1999; 20: 1455-70. https://doi.org/10.1016/S0196-9781(99)00157-6
- van den Pol AN. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci 1999; 19: 3171-82. https://doi.org/10.1523/jneurosci.19-08-03171.1999
- Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, Wyles M, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001; 92: 81-90. https://doi.org/10.1016/S0304-3959(00)00470-X
- Hervieu GJ, Cluderay JE, Harrison DC, Roberts JC, Leslie RA. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001; 103: 777-97. https://doi.org/10.1016/S0306-4522(01)00033-1
- Kimura M, Kawai Y, Ishikawa M, Shibutani K, Uchida R, Eguchi Y, et al. Effects of lidocaine and orexin on [Ca2+ ]i in dosal root ganglion neuron of rat segmental spinal nerve ligation model. Jpn Pharmacol Ther 2014; 42: 723-34.
- Zhou HY, Chen SR, Chen H, Pan HL. Opioid-induced longterm potentiation in the spinal cord is a presynaptic event. J Neurosci 2010; 30: 4460-6. https://doi.org/10.1523/JNEUROSCI.5857-09.2010
- Watanabe S, Kuwaki T, Yanagisawa M, Fukuda Y, Shimoyama M. Persistent pain and stress activate pain-inhibitory orexin pathways. Neuroreport 2005; 16: 5-8. https://doi.org/10.1097/00001756-200501190-00002
- Azhdari-Zarmehri H, Semnanian S, Fathollahi Y. Orexin-A modulates firing of rat rostral ventromedial medulla neurons: an in vitro study. Cell J 2015; 17: 163-70.
- Bannister K, Lee YS, Goncalves L, Porreca F, Lai J, Dickenson AH. Neuropathic plasticity in the opioid and non-opioid actions of dynorphin A fragments and their interactions with bradykinin B2 receptors on neuronal activity in the rat spinal cord. Neuropharmacology 2014; 85: 375-83. https://doi.org/10.1016/j.neuropharm.2014.06.005
- Kajander KC, Sahara Y, Iadarola MJ, Bennett GJ. Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides 1990; 11: 719-28. https://doi.org/10.1016/0196-9781(90)90187-A
- Vanderah TW, Gardell LR, Burgess SE, Ibrahim M, Dogrul A, Zhong CM, et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 2000; 20: 7074-9. https://doi.org/10.1523/JNEUROSCI.20-18-07074.2000
- Yamamoto T, Nozaki-Taguchi N, Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol 2002; 137: 170-6. https://doi.org/10.1038/sj.bjp.0704851